Evotec, Mesoblast, and NetEase report market movements and earnings

Several companies reported significant financial activity and market movements. Evotec AG saw its shares gap down to $1.9191 following a previous close of $1.96. Recent analyst activity includes HC Wainwright lowering its price target from $7.00 to $4.00 while maintaining a buy rating, and Berenberg Bank downgrading the stock from buy to hold.

Mesoblast Limited also experienced a share price gap down, opening at $16.98 after a previous close of $17.43. The company holds a market capitalization of $2.21 billion and has received a sell rating from Weiss Ratings.

NetEase, Inc. conducted its Q2 2026 earnings conference call, featuring participation from CEO William Ding and other executives. The call addressed forward-looking statements and financial performance risks as outlined in regulatory filings.